
Liver Drug Could Reverse Scarring, Mouse Study Finds
Adults with advanced liver scarring may one day benefit, as the drug is already in phase 3 human trials for other uses.
Weight management and obesity get covered through science, policy and the broader conversations around them. Reporting here takes in drug approvals, clinical research, dietary interventions and the access questions that follow.

Adults with advanced liver scarring may one day benefit, as the drug is already in phase 3 human trials for other uses.
November 5, 2026
Weight-Loss Drug Candidate Cuts Liver Fat in TrialAdults with obesity and fatty liver may one day have an option that targets both, though current results come from a small early-stage study.
November 5, 2026
Experimental Injectable Targets Belly Fat CellsEarly trials suggest the compound reduces deep abdominal fat, though it remains experimental and unproven for general use.
November 4, 2026
Vitamin D Receptor Linked to Fat Loss in MiceAdults worried about sagging skin and thinning fat should note the finding comes from animal research only.
November 4, 2026
Body Composition Shapes Metabolic Health RiskIn a large UK study, the share of body weight made of fat-free mass tracked with lower metabolic syndrome risk.
November 3, 2026
Pfizer's Ecnoglutide Weight Drug Launches in ChinaAdults weighing GLP-1 treatments can see how Pfizer is making the drug available through self-pay access in China.
November 3, 2026
GLP-1 Misinformation Forces Clinicians to CorrectClinicians say they correct false GLP-1 weight loss claims weekly, and counterfeit sellers are facing new scrutiny.
November 2, 2026
Midlife Weight Changes May Shape Later Heart HealthIf you are in your 40s or 50s, a preliminary study suggests weight shifts now may affect blood pressure and cholesterol later on.
November 2, 2026
Semaglutide Shows Largest Weight Loss in SchizophreniaFor people taking antipsychotics for schizophrenia, a 95-trial analysis points to GLP-1 drugs as the strongest option for weight control.
November 2, 2026
Six New Weight-Loss Drugs Move Through TrialsAdults seeking weight-loss treatment may see more options in coming years, though none of these candidates are yet approved.
November 2, 2026
Testosterone Helps Bone Health in Prader-WilliMales with Prader-Willi syndrome on testosterone saw steadier bone density and more lean mass over five years in a Dutch study.
Reporting here spans medication approvals and long-term outcome data, obesity prevalence research, dietary intervention studies, and weight-loss surgery and its effects. It also follows the policy and insurance dimensions that determine which options are available and to whom. Efficacy and access are treated as separate questions, since approval of a treatment does not resolve whether most people can use it. Body image and the cultural framing of weight sit alongside the clinical reporting, because the two are rarely fully separable.